160 related articles for article (PubMed ID: 8291340)
1. [Study of a group of diabetic patients enrolled in the INAMI convention "Self-monitoring of blood glucose"].
Buysschaert M; Lambert L; Donckier J; Jamart J
Acta Clin Belg; 1993; 48(5):316-23. PubMed ID: 8291340
[TBL] [Abstract][Full Text] [Related]
2. Facilitating access to glucometer reagents increases blood glucose self-monitoring frequency and improves glycaemic control: a prospective study in insulin-treated diabetic patients.
Nyomba BL; Berard L; Murphy LJ
Diabet Med; 2004 Feb; 21(2):129-35. PubMed ID: 14984447
[TBL] [Abstract][Full Text] [Related]
3. [Treatment and glycemic control of 1200 diabetic patients enrolled at the National Institute of Disease-Disability Insurance diabetes convention].
Buysschaert M; Maes M; Hermans MP
Acta Clin Belg; 1997; 52(4):211-8. PubMed ID: 9412121
[TBL] [Abstract][Full Text] [Related]
4. Effect of data management on a central server on HbA1c levels in insulin-requiring patients.
Davidson MB; Lewis G
Diabetes Care; 2000 May; 23(5):706-7. PubMed ID: 10834438
[No Abstract] [Full Text] [Related]
5. Relationship between metabolic control and self-monitoring of blood glucose in insulin-treated patients with diabetes mellitus.
Soto González A; Quintela Fernández N; Pumar López A; Darias Garzón R; Rivas Fernández M; Barberá Comes G
Endocrinol Nutr; 2015 May; 62(5):233-9. PubMed ID: 25814324
[TBL] [Abstract][Full Text] [Related]
6. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
Vinagre I; Álvarez P; García N; Roura G; Conget I;
Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
[TBL] [Abstract][Full Text] [Related]
7. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
[TBL] [Abstract][Full Text] [Related]
8. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes.
Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240
[TBL] [Abstract][Full Text] [Related]
9. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
Rama Chandran S; A Vigersky R; Thomas A; Lim LL; Ratnasingam J; Tan A; S L Gardner D
Diabetes Technol Ther; 2020 Feb; 22(2):103-111. PubMed ID: 31502876
[No Abstract] [Full Text] [Related]
10. Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.
Yamada M; Okada S; Oda H; Nakajima Y; C Bastie C; Kasai Y; Osaki A; Shimoda Y; Shibusawa R; Uehara R; Saito T; Ozawa A; Yamada E
Endocr J; 2020 May; 67(5):531-536. PubMed ID: 32023560
[TBL] [Abstract][Full Text] [Related]
11. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
[TBL] [Abstract][Full Text] [Related]
12. [Glycosylated hemoglobin in diabetic children under 18 years old enrolled in the INAMI study for the purpose of self-monitoring of glucose at home].
Dorchy H; Roggemans MP; Willems D
Acta Clin Belg; 1997; 52(6):405-6. PubMed ID: 9489138
[No Abstract] [Full Text] [Related]
13. Patterns of blood glucose monitoring in relation to glycemic control among patients with type 2 diabetes in the UK.
Secnik K; Yurgin N; Lage MJ; McDonald-Everett C
J Diabetes Complications; 2007; 21(3):181-6. PubMed ID: 17493552
[TBL] [Abstract][Full Text] [Related]
14. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
Billings LK; Parkin CG; Price D
Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
Puhr S; Calhoun P; Welsh JB; Walker TC
Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
[TBL] [Abstract][Full Text] [Related]
16. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
17. Frequency of blood glucose testing among insulin-treated diabetes mellitus patients in the United Kingdom.
Lee WC; Smith E; Chubb B; Wolden ML
J Med Econ; 2014 Mar; 17(3):167-75. PubMed ID: 24359593
[TBL] [Abstract][Full Text] [Related]
18. Monitoring glycemia in diabetes.
Healy SJ; Dungan KM
Med Clin North Am; 2015 Jan; 99(1):35-45. PubMed ID: 25456642
[TBL] [Abstract][Full Text] [Related]
19. The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM).
Sartore G; Chilelli NC; Burlina S; Di Stefano P; Piarulli F; Fedele D; Mosca A; Lapolla A
Acta Diabetol; 2012 Dec; 49 Suppl 1():S153-60. PubMed ID: 22466072
[TBL] [Abstract][Full Text] [Related]
20. How often patients on insulin therapy measure postprandial glycemia and modify insulin doses accordingly? From an on-line survey in insulin-treated diabetes patients in Spain.
Lecumberri Pascual E; Tejera Pérez C; Muñoz-Garach A; Javier Ampudia-Blasco F
Diabetes Res Clin Pract; 2019 Aug; 154():43-51. PubMed ID: 31226281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
